Patent ID: 9532977
Date: 2017-01-03
CPC Classifications: A61K

Claim:
1. A controlled release oral dosage form comprising: (i) a compound of formula (I): or a pharmaceutically acceptable polymorph, solvate or hydrate thereof, in an amount of about 10% by weight; (ii) sodium carboxymethyl cellulose in an amount of about 34.5% by weight; (iii) poly(butyl methacylate-co-2-dimethylaminoethyl methacrylate-co-methyl methacrylate) (1:2:1) in an amount of about 5% by weight; (iv) sodium alginate in an amount of about 19% by weight; (v) sodium bicarbonate in an amount of about 5% by weight; (vi) citric acid in an amount of about 8% by weight; (vii) croscarmellose sodium in an amount of about 5% by weight; (viii) magnesium stearate in an amount of about 1.5% by weight; (ix) mannitol in an amount of about 11.5% by weight and (x) silicon dioxide in an amount of about 0.5% by weight.